Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026)

Pacific Biosciences Of California's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 82.9% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 82.9% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, changed 0.0% from the prior year.
• Other Non-Current Assets grew to $1.6 million in Q1 2026 per PACB's latest filing, from $1.5 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $13.3 million in Q1 2023 and bottomed at $1.5 million in Q4 2024.
• The 5-year median for Other Non-Current Assets is $5.0 million (2022), against an average of $6.2 million.
• Across the five-year window, Other Non-Current Assets surged 7335.82% in 2022 and plunged 82.9% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.9 million in 2022, then retreated by 17.11% to $2.4 million in 2023, then plunged by 36.75% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then rose by 2.55% to $1.6 million in 2026.
• Per Business Quant, the three latest PACB Other Non-Current Assets figures stand at $1.6 million (Q1 2026), $1.5 million (Q4 2025), and $8.8 million (Q3 2025).